Lv2
200 积分 2024-03-28 加入
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
15天前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
15天前
已完结
SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling
15天前
已完结
Abstract 502: ISM3091, a novel selective USP1 inhibitor as a targeted anticancer therapy
1个月前
已关闭
Abstract 2771: KSQ-4279 mediated USP1 inhibition induces replication associated DNA gaps that contribute to cell death
1个月前
已完结
Identifying USP1 Inhibitors with Allosteric Effect on Its Triple Catalytic Center through Virtual Screening
1个月前
已完结
Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers
1个月前
已完结
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
1个月前
已完结
Structural and Biochemical Insights into the Mechanism of Action of the Clinical USP1 Inhibitor, KSQ-4279
1个月前
已完结
The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy
2个月前
已完结
皖公网安备34019202002308
